GANGAPHARM logo

Ganga Pharmaceuticals Ltd

GANGAPHARM·BSE·
₹12.50▲ +0.00 (+0.00%)
Market Cap7.39 Cr
PE Ratio73.53
Volume16,000
Day High - Low12.50 - 12.00
52W High-Low13.97 - 9.35

Ganga Pharmaceuticals Ltd (GANGAPHARM): company summary

Ganga Pharmaceuticals Ltd (GANGAPHARM) is a micro-cap Healthcare company valued at ₹7 crore operating in Pharmaceuticals on the NSE and BSE.

Ganga Pharmaceuticals Ltd (GANGAPHARM) is a micro-cap Healthcare company valued at ₹7 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move
Ganga Pharmaceuticals Ltd last traded at ₹12.5, unchanged on the day.
Financial performance
Revenue has been growing steadily at 7.9% a year over three years; profit grew 35.7% a year, ahead of revenue — margins are expanding. Return on equity is 1.3%.
Valuation multiples
The stock trades at 73.5 times earnings, a premium to the Healthcare median of 32.2, 0.89 times book value.

Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
4.9/10
Weak
Fair Value
Sign in to see
ROE
1.30%
Weak
P/E
73.53x
Expensive
Debt / Equity
0.13
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day₹12.00
₹12.50
52W₹9.35
₹13.97
DocStoX take

Supported by risk (7.9) and momentum (7.5), but held back by quality (2.1). Risk looks strong at 7.9, but that is offset by quality at 2.1 and valuation at 2.4. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
4.9
/10
Weak
Quality
Weak
ROE 1.3%
Valuation
Expensive
P/E 73.5×
Growth
Steady
Revenue +6.4% 5Y CAGR
Risk
Low risk
D/E 0.13
Momentum
Strong
68% of 52-week range

At a glance

Market Cap
₹7 Cr
52W High / Low
₹14 / ₹9
Dividend Yield
0.00%
Promoter Holding
50.91%
EPS (TTM)
₹0.17
Book Value
₹14.06

Key highlights

  • Profit compounding 38% a year
  • Low leverage — D/E 0.13
  • Profitable in all of the last 5 years
  • Quality is weak (2.1/10)
  • Valuation is weak (2.4/10)
3 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore Ganga Pharmaceuticals Ltd’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Ganga Pharmaceuticals Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries LtdDivis Laboratories LtdTorrent Pharmaceuticals LtdApollo Hospitals Enterprise LtdZydus Lifesciences LtdCipla LtdLaurus Labs LtdMax Healthcare Institute LtdDr Reddys Laboratories LtdAurobindo Pharma LtdLupin LtdManipal Health Enterprises Ltd

Compare Ganga Pharmaceuticals Ltd with peers

Ganga Pharmaceuticals Ltd vs Sun Pharmaceutical Industries LtdGanga Pharmaceuticals Ltd vs Divis Laboratories LtdGanga Pharmaceuticals Ltd vs Torrent Pharmaceuticals LtdGanga Pharmaceuticals Ltd vs Apollo Hospitals Enterprise LtdGanga Pharmaceuticals Ltd vs Zydus Lifesciences LtdGanga Pharmaceuticals Ltd vs Cipla Ltd

Related tools & concepts

Value Ganga Pharmaceuticals Ltd with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing